Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results
Embecta (Nasdaq: EMBC) reported first quarter fiscal 2026 financial results on February 5, 2026.
Rhea-AI Summary
Embecta (Nasdaq: EMBC) reported first quarter fiscal 2026 financial results on February 5, 2026. The company directs investors to its Investor Relations website for the detailed earnings release and presentation.
Embecta hosted a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET on February 5, 2026, with a replay available beginning at 11:00 a.m. ET on February 5, 2026 and archived for one year on the investor relations site.
Positive
- None.
Negative
- None.
Details
News Market Reaction – EMBC
In the Feb 5 session, EMBC declined 7.75%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Earnings call time
- 8:00 a.m. ET
- Start of Q1 FY2026 conference call on Feb 5, 2026
- Replay availability
- 11:00 a.m. ET
- Webcast replay begins on Feb 5, 2026
- Replay duration
- 1 year
- Earnings call replay archived on investor relations website
Previous Earnings Reports
-
Revenues declined year-over-year and FY2026 guidance framed continued top-line pressure.
-
Strong revenue growth, higher adjusted EPS, debt reduction and raised FY2025 guidance.
-
Revenue declines in U.S. and international markets despite margin improvement and debt paydown.
-
Revenue contraction across regions while maintaining dividends and executing restructuring plans.
-
Modest revenue growth plus major restructuring and guidance for FY2025 supported a strong rally.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported first quarter fiscal 2026 financial results.
Visit the company’s Investor Relations website at http://investors.embecta.com to view the detailed first quarter fiscal 2026 earnings press release and investor presentation.
The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, February 5, 2026, which is accessible here, or access the teleconference here.
A webcast replay of the call will be available beginning at 11:00 a.m. ET on February 5, 2026, via the embecta investor relations website and archived on the website for one year.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
| Contacts: | |
| Media Christian Glazar Sr. Director, Corporate Communications 908-821-6922 Contact Media Relations | Investors Pravesh Khandelwal VP, Head of Investor Relations 551-264-6547 Contact IR |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.